RWC-340B

A major 340B win. The Fifth Circuit unanimously upheld Louisiana’s contract pharmacy access law — protecting providers’ ability to serve patients through the 340B program. Another step forward for patient access and safety-net care.

On February 18, 2026, RWC-340B sent a letter to @EliLillyandCo's CEO objecting to the drug manufacturer’s policy requiring covered entities to submit claims-level data for all 340B utilization. We called their new policy an unprecedented and unequivocal violation of federal law. Days later, @novonordiskus announced that it was implementing the same data requirements for all 340B claims, so we sent a letter to their CEO too. Their policy might not be unprecedented, since Eli Lilly tried it first, but it too is an unequivocal violation of federal law. The policy violates the 340B statute and the pharmaceutical pricing agreement with the Secretary of Health and Human Services by overcharging covered entities that refuse to acquiesce to their conditions. Moreover, the policy would result in significant administrative costs impacting RWCs’ ability to care for our patients. rwc340b.org/rwc-340b-lette…

The 340B rebate model RFI deadline is April 20! HRSA is seeking comment on a proposed rebate framework that would fundamentally change how the 340B program operates. For Ryan White Clinics and other safety-net providers, this is not a technical adjustment – it is a structural shift that would: • Move financial risk onto providers • Increase administrative and compliance burden • Create uncertainty around whether rebates are paid • Divert resources away from patient care 340B savings sustain medications, primary care, mental health services, and case management for low-income and uninsured patients – at no cost to taxpayers. Please – make your voices heard before April 20! federalregister.gov/documents/2026…

94 bipartisan House members just sent a letter calling on appropriators to block a 340B rebate model in the FY2027 spending bill. We stand with them. A rebate model forces Ryan White clinics to front full drug costs to manufacturers and wait – cash we don't have, patients we can't afford to shortchange. 340breport.com/nearly-100-bip…

States are tightening HIV drug assistance programs as costs rise and budgets tighten - putting consistent access to treatment at risk. In @stateline_news, Amber Tynan - Officer of Ryan White Clinics for 340B Access and CEO of @BigBendCares - explains what’s at stake. “Progress depends on one thing: consistent access to treatment.” stateline.org/2026/03/10/sta…

The wrong track: 340B Rebate model Act now, or this road leads to poorer HIV care.

The 340B rebate model RFI deadline is extended to April 20. A rebate scheme would shift financial risk to clinics, increase administrative costs, and divert resources from patient care. 340B savings sustain medications and essential services for low-income patients – at no cost to taxpayers. We encourage providers to weigh in. rwc340b.org/hrsa-publishes…

RWC Officer Emily Blaiklock was quoted in a recent Virginia WHRO report examining how the loss of ACA premium tax credits and changes to drug rebates could jeopardize HIV treatment access for thousands of Virginians. RWC continues to serve as a trusted source for media covering 340B and HIV policy. whro.org/health/2026-02…

@HRSAgov issued an RFI on whether to move forward with a #340B rebate model. Stakeholder feedback should make clear what providers already know: a rebate model would harm safety-net clinics and the patients they serve. Requiring providers to pay upfront and wait for reimbursement creates financial risk and administrative burden that threatens care access. #DEFEND340B #Protect340B rwc340b.org/hrsa-takes-ste…

📢 340B Provider Alert Effective Feb. 1, 2026, Eli Lilly will require covered entities to submit claims-level data for all Lilly products dispensed — including in-house pharmacies — via 340B ESP. Failure to comply could impact 340B pricing access. rwc340b.org/eli-lilly-anno…

PhRMA made $521M – and spent millions funding groups attacking 340B, contract pharmacies, and safety-net providers. This is a coordinated campaign to weaken a program that patients rely on. #Protect340B #Defend340B 340breport.com/new-tax-filing…

A major win for the 340B community: DOJ has told the First Circuit it plans to drop its appeal and pause litigation over HRSA’s 340B rebate pilot, signaling the agency will return the policy for reconsideration. The government and hospital plaintiffs are now in discussions to send the rebate model back to HRSA, following court rulings that faulted the agency for failing to follow proper process and account for the real-world impact on providers. This is a clear sign that provider advocacy is being heard - and that flawed policies that would have disrupted patient care and the 340B program are being reevaluated. Shannon Burger of Cempa Community Care is quoted in Bloomberg Law. news.bloomberglaw.com/ip-law/hhs-sig…

Rural healthcare is complex, because every community has it's own unique needs. That's why 340B is so important – it keeps care local, so local health centers can make the call on what their communities need. It's not a one-size-fits-all program, because healthcare isn't one-size-fits-all.

@PhRMA did you miss our red pen? Helping patients receive affordable care is what 340B does. Marking up healthcare costs is what you do. Confusing? Not really. But you'll get it someday.

You might ask why we continue to stand on our soapbox and defend 340B. Well, the answer is simple: patients need it, rely on it, and often would not receive healthcare without it. 340B keeps care affordable and accessible for underserved communities -- rural, urban and everything in-between, without costing taxpayers a dime. Who wouldn't fight for that?

What happens when the going gets tough? Programs like 340B get going to help the communities that need it most. Still have questions? Get the facts here: rwc340b.org

Lucky for us, we've had the same new years resolution for 33 years. We'll keep fighting for 340B, rural health, and underserved communites all year long. Now you? Time to hit the gym, drink more water, and lay off the sweets. We'll check back soon!

According to @RxPricing 23% of Big Pharma's profit margin is 10 times higher than other sectors of the drug industry??? Shocker. Big Pharma loves to play the blame game. Avoiding accountabilty while keeping drug prices high? Sounds about right!!!! csrxp.org/csrxp-analysis…

Progress against HIV is real, but the U.S. still sees 30,000+ new cases annually. 340B helps clinics reach patients where they need care most. hiv.gov/hiv-basics/ove…

Over the river and through the woods, to Rural Clinics we go. That's how the song goes right? That's the jingle for 340B as we continue to support rural communities through all seasons of the year.